247 related articles for article (PubMed ID: 37556531)
21. PR-DUB preserves Polycomb repression by preventing excessive accumulation of H2Aub1, an antagonist of chromatin compaction.
Bonnet J; Boichenko I; Kalb R; Le Jeune M; Maltseva S; Pieropan M; Finkl K; Fierz B; Müller J
Genes Dev; 2022 Oct; 36(19-20):1046-1061. PubMed ID: 36357125
[TBL] [Abstract][Full Text] [Related]
22. BAP1 enhances Polycomb repression by counteracting widespread H2AK119ub1 deposition and chromatin condensation.
Conway E; Rossi F; Fernandez-Perez D; Ponzo E; Ferrari KJ; Zanotti M; Manganaro D; Rodighiero S; Tamburri S; Pasini D
Mol Cell; 2021 Sep; 81(17):3526-3541.e8. PubMed ID: 34186021
[TBL] [Abstract][Full Text] [Related]
23. Familial and Somatic
Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ
Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740
[TBL] [Abstract][Full Text] [Related]
24. In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones.
Masclef L; Maxime U; Ahmed O; Sen Nkwe N; Barbour H; Iannantuono NVG; Boubekeur A; Daou S; Affar EB
J Vis Exp; 2019 Jul; (149):. PubMed ID: 31403616
[TBL] [Abstract][Full Text] [Related]
25. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.
Wang L; Birch NW; Zhao Z; Nestler CM; Kazmer A; Shilati A; Blake A; Ozark PA; Rendleman EJ; Zha D; Ryan CA; Morgan MAJ; Shilatifard A
Nat Cancer; 2021 May; 2(5):515-526. PubMed ID: 35122023
[TBL] [Abstract][Full Text] [Related]
26. Polycomb-dependent histone H2A ubiquitination links developmental disorders with cancer.
Tamburri S; Conway E; Pasini D
Trends Genet; 2022 Apr; 38(4):333-352. PubMed ID: 34426021
[TBL] [Abstract][Full Text] [Related]
27. B-cell intrinsic regulation of antibody mediated immunity by histone H2A deubiquitinase BAP1.
Liang Y; Wang H; Seija N; Lin YH; Tung LT; Di Noia JM; Langlais D; Nijnik A
Front Immunol; 2024; 15():1353138. PubMed ID: 38529289
[TBL] [Abstract][Full Text] [Related]
28. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
Okino Y; Machida Y; Frankland-Searby S; Machida YJ
J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
[TBL] [Abstract][Full Text] [Related]
29. A common ancestry for BAP1 and Uch37 regulators.
Sanchez-Pulido L; Kong L; Ponting CP
Bioinformatics; 2012 Aug; 28(15):1953-6. PubMed ID: 22645167
[TBL] [Abstract][Full Text] [Related]
30. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
Lee SW; Youn H; Kim EJ; Um SJ
Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
[TBL] [Abstract][Full Text] [Related]
31. Role of histone H2A ubiquitination in Polycomb silencing.
Wang H; Wang L; Erdjument-Bromage H; Vidal M; Tempst P; Jones RS; Zhang Y
Nature; 2004 Oct; 431(7010):873-8. PubMed ID: 15386022
[TBL] [Abstract][Full Text] [Related]
32. MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer.
Tsuboyama N; Szczepanski AP; Zhao Z; Wang L
Genome Biol; 2022 Sep; 23(1):206. PubMed ID: 36180891
[TBL] [Abstract][Full Text] [Related]
33. Goldilocks meets Polycomb.
Verrijzer CP
Genes Dev; 2022 Oct; 36(19-20):1043-1045. PubMed ID: 36460465
[TBL] [Abstract][Full Text] [Related]
34. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
Elife; 2021 Jun; 10():. PubMed ID: 34170818
[TBL] [Abstract][Full Text] [Related]
35. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.
Srivastava A; Ritesh KC; Tsan YC; Liao R; Su F; Cao X; Hannibal MC; Keegan CE; Chinnaiyan AM; Martin DM; Bielas SL
Hum Mol Genet; 2016 Feb; 25(3):597-608. PubMed ID: 26647312
[TBL] [Abstract][Full Text] [Related]
36. Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.
Peng H; Cassel J; McCracken DS; Prokop JW; Sementino E; Cheung M; Collop PR; Polo A; Joshi S; Mandell JP; Ayyanathan K; Hinds D; Malkowicz SB; Harbour JW; Bowcock AM; Salvino J; Kennedy EJ; Testa JR; Rauscher FJ
Mol Cancer Res; 2021 Jul; 19(7):1099-1112. PubMed ID: 33731362
[TBL] [Abstract][Full Text] [Related]
37. Polycomb group-mediated histone H2A monoubiquitination in epigenome regulation and nuclear processes.
Barbour H; Daou S; Hendzel M; Affar EB
Nat Commun; 2020 Nov; 11(1):5947. PubMed ID: 33230107
[TBL] [Abstract][Full Text] [Related]
38. BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome.
Fursova NA; Turberfield AH; Blackledge NP; Findlater EL; Lastuvkova A; Huseyin MK; Dobrinić P; Klose RJ
Genes Dev; 2021 May; 35(9-10):749-770. PubMed ID: 33888563
[TBL] [Abstract][Full Text] [Related]
39. Tumor suppressor ASXL1 is essential for the activation of INK4B expression in response to oncogene activity and anti-proliferative signals.
Wu X; Bekker-Jensen IH; Christensen J; Rasmussen KD; Sidoli S; Qi Y; Kong Y; Wang X; Cui Y; Xiao Z; Xu G; Williams K; Rappsilber J; Sønderby CK; Winther O; Jensen ON; Helin K
Cell Res; 2015 Nov; 25(11):1205-18. PubMed ID: 26470845
[TBL] [Abstract][Full Text] [Related]
40. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.
Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T
Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
